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Dendropanax morbifera Léveille extract
ameliorates cadmium-induced impairment
in memory and hippocampal neurogenesis
in rats
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Yeo Sung Yoon1, Dae Won Kim2 and In Koo Hwang1,4*
Abstract
Background: Cadmium leads to learning and memory impairment. Dendropanax morbifera Léveille stem extract
(DMS) reduces cadmium-induced oxidative stress in the hippocampus. We investigated the effects of DMS on
cadmium-induced impairments in memory in rats.
Methods: Cadmium (2 mg/kg), with or without DMS (100 mg/kg), was orally administered to 7-week-old
Sprague-Dawley rats for 28 days. Galantamine (5 mg/kg), an acetylcholinesterase inhibitor, was intraperitoneally
administered as a positive control. A novel-object recognition test was conducted 2 h after the final administration.
Cell proliferation and neuroblast differentiation were assessed by immunohistochemistry for Ki67 and doublecortin,
respectively. Acetylcholinesterase activity in the synaptosomes of the hippocampus was also measured based on the
formation of 5,5′-dithio-bis-acid nitrobenzoic acid.
Results: An increase in the preferential exploration time of new objects was observed in both vehicle-treated and
cadmium-treated rats. In addition, DMS administration increased cell proliferation and neuroblast differentiation in the
dentate gyrus of vehicle-treated and cadmium-treated rats. Acetylcholinesterase activity in the hippocampal synaptosomes
was also significantly higher in the DMS-treated group than in the vehicle-treated group. The effect of DMS on cadmium-
induced memory impairment and cell proliferation in the hippocampus was comparable to that of galantamine.
Conclusions: These results suggest that DMS ameliorates cadmium-induced memory impairment via increase in cell
proliferation, neuroblast differentiation, and acetylcholinesterase activity in the hippocampus. The consumption of DMS
may reduce cadmium-induced neurotoxicity in animals or humans.
Keywords: Dendropanax morbifera extract, Cadmium, Neurogenesis, Memory, Acetylcholinesterase
Background
Improvements in medical technology have caused sharp
increases in the population of humans aged 65 years and
above, and South Korea is becoming one of the most
rapidly aging societies in the world. One of the most
important problems in an aging society is the decrease
in quality of life caused by mild cognitive impairment or
the cognitive symptoms of neuropsychiatric disorders,
such as schizophrenia [1, 2]. Some therapeutic agents,
including donepezil, galantamine (GAL), and meman-
tine, improve cognitive function in Alzheimer’s disease
[1, 2]. However, natural extracts or compounds have
been recent targets of research because of their potential
for fewer associated side effects compared to many
chemical compounds.
Several lines of evidence suggest that newly generated
cells in the subgranular zone of the dentate gyrus can
proliferate, differentiate, and integrate into the granule
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cell layer, where they participate in hippocampal func-
tions, such as learning and memory [3, 4]. Proliferating
cells with active cell cycles in the subgranular zone of
the dentate gyrus express Ki67 [5] and adult-born neuro-
blasts express doublecortin (DCX) from days 1 to 28 of
cell age [6, 7]. The rate of neurogenesis in the hippo-
campus is associated with spatial-memory consolidation
[8]. The novel-object recognition test is one of most
reliable methods of measuring hippocampal-dependent
memory because animals remember the familiar object
and increase their explorative activity (approach fre-
quency and time spent exploring the novel object) [9].
Adult neurogenesis is required only when the reactiva-
tion session involves novelty and this process drives the
updating of stored object recognition memories. Stimu-
lation of endogenous hippocampal neurogenesis rein-
forces the hippocampal network and improves learning
and memory, whereas ablation of hippocampal neuro-
genesis by γ-ray irradiation of the dentate gyrus leads to
cognitive impairment [10–13]. In particular, the inhib-
ition of WNT signaling by dominant-negative WNT sig-
nificantly reduces novel-object recognition memory [13].
Dendropanax morbifera Léveille is an endemic plant
found in southwestern Korea. The plant has been used
in traditional medicine for the treatment of skin prob-
lems, infectious diseases, headaches, and other maladies
[14]. D. morbifera Léveille stem extract (DMS) decreases
free radical damage in various organs, including the
hippocampus [15, 16]. In previous studies, we demon-
strated that DMS facilitates the excretion of cadmium
and reduces cadmium-induced oxidative damage in the
hippocampus [15].
Cadmium is one of the most harmful heavy metals be-
cause it increases the permeability of the blood-brain
barrier and penetrates the brain, leading to intracellular
accumulation, cellular dysfunction, and cerebral edema
[16–18]. The potential protective effects of DMS on hip-
pocampal function and neuroblast differentiation after
cadmium exposure have not been examined. Therefore,
in this study, we established a model of cadmium-
induced memory impairment in rats and investigated
the effects of DMS administration on cell proliferation




Male Sprague-Dawley rats were purchased from Orient
Bio Inc. (Seongnam, South Korea). Rats were housed in
a conventional animal facility at 23 °C with 60 % humid-
ity, a 12 h/12 h light/dark cycle, with ad libitum access
to food and tap water. The handling and care of the
animals conformed to guidelines established in compli-
ance with current international laws and policies (NIH
Guide for the Care and Use of Laboratory Animals, NIH
Publication No. 85–23, 1985, revised 1996) and were ap-
proved by the Institutional Animal Care and Use Com-
mittee of Seoul National University (SNU-130522-1). All
experiments were conducted with an effort to minimize
the number of animals used and the suffering caused by
the procedures used in the study.
Preparation of DMS
Fresh D. morbifera Léveille was obtained from Hambakjae
Farm (Jeju, Korea). The plant was authenticated by two
practitioners of traditional Asian medicine and a voucher
specimen was deposited in our laboratory (Deposition
number: 2012–030). Stems from the plant samples (100 g)
were chopped, blended, soaked in 2 L of 80 % ethanol,
and refluxed thrice at 20 °C for 2 h. Insoluble materials
were removed by centrifugation at 10,000 g for 30 min,
and the resulting supernatant was concentrated and
freeze-dried to yield a powder (yield: 3.3 %). Before each
experiment, the dried extract was dissolved in distilled
and deionized water.
Administration of cadmium, DMS, and GAL
Cadmium chloride (CdCl2) was obtained from Sigma-
Aldrich (St. Louis, MO, USA). Animals were divided into 5
treatment groups (n = 10 in each group): 1) treatment with
vehicle (distilled water); 2) treatment with 100 mg/kg DMS;
3) treatment with 2 mg/kg CdCl2; 4) treatment with CdCl2
and DMS; and 5) treatment with CdCl2 and 5 mg/kg GAL
(Sigma-Aldrich). Cadmium and DMS were dissolved in
distilled water and administered to 7-week-old rats, once a
day for 28 days using a gavage, while GAL was dissolved in
physiological saline and administered intraperitoneally for
28 days. GAL was used as a positive control in this study,
owing to its action as an acetylcholinesterase (AChE)
inhibitor and its ability for improving memory and promot-
ing neurogenesis as demonstrated previously [19–21].
Novel-object recognition test
The test was performed as described by Foyet et al. [22].
The apparatus consisted of an open box (80 × 80 ×
40 cm high) made of black acryl. The floor was covered
with woodchip bedding, which was moved around be-
tween trials and testing days to prevent the build-up of
odor in certain places. The objects to be discriminated
were made of a solid metal, and their weight ensured
that the rats could not displace them. The objects were
cleaned with bleach to remove the smell of the rats.
After 25 days of vehicle, cadmium, DMS and/or GAL
treatment, each rat was allowed to explore the apparatus
for 2 min. On the testing day (at 28 days of treatment),
2 h following the final treatment, a session of two trials,
2 min each, was carried out. In the “sample” trial (T1), 2
identical objects were placed in opposite corners of the
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apparatus. A rat was placed in the apparatus and was left
to explore these two identical objects. After T1, the rat
was placed back in its home cage and an inter-trial inter-
val of 1 h was given. Subsequently, the “choice” trial
(T2) was performed. In T2, a new object replaced one of
the objects that had been presented in T1. The rats were
exposed to the two different objects: one familiar and
one new. Exploration was defined as directing the nose
toward the object at a distance of no more than 2 cm
and/or touching the object with the nose. From these
measurements, a series of variables were calculated: the
total time spent exploring the 2 identical objects in T1
and time spent exploring the 2 different objects, familiar
and new, in T2.
The distinction between familiar and new objects in
T2 was determined by comparing the time spent explor-
ing familiar objects with that spent exploring N. The
discrimination index (DI) represents the difference in
exploration time expressed as a proportion of the total
time spent exploring the two objects in T2.
Tissue processing
For histology, the animals (n = 5 in each group) were
anesthetized by an intraperitoneal injection of 1 g/kg
urethane (Sigma-Aldrich) directly after the novel-
object recognition test. Rats were perfused transcar-
dially with 0.1 M phosphate-buffered saline (PBS,
pH 7.4) followed by 4 % paraformaldehyde in 0.1 M
PBS. The brains were dissected out and postfixed in
the same fixative for 12 h. The brain tissues were
cryoprotected by infiltration with 30 % sucrose over-
night. Thirty-micrometer thick brain sections were
serially sectioned in the coronal plane using a cryostat
(Leica, Wetzlar, Germany) and collected in six-well
plates containing PBS for further processing.
Immunohistochemistry for Ki67 and DCX
To obtain accurate data for immunohistochemistry, the
free-floating sections from all animals were processed
carefully under the same conditions. Tissue sections
were selected between 3.00 and 4.08 mm posterior to
the bregma with reference to a rat brain atlas [23] for
each animal. Ten sections, 90-μm apart from each other,
were sequentially treated with 0.3 % hydrogen peroxide
(H2O2) in PBS for 30 min and 10 % normal horse serum
in 0.05 M PBS for 30 min. They were then incubated
with a rabbit anti-Ki67 antibody (1:1,000; Abcam,
Cambridge, UK) or goat anti-DCX antibody (1:50; Santa
Cruz Biotechnology, Santa Cruz, CA) overnight at 25 °C
and subsequently treated with either a biotinylated goat
anti-mouse IgG or horse anti-goat IgG, and a streptavidin-
peroxidase complex (1:200, Vector, Burlingame, CA).
Sections were visualized by reaction with 3,3′-diami-
nobenzidine tetrachloride (Sigma) in 0.1 M Tris-HCl
buffer (pH 7.2) and dehydrated and mounted in
Canada balsam (Kanto, Tokyo, Japan) onto gelatin-
coated slides.
The Ki67-positive cells were enumerated using an
image-analysis system equipped with a computer-based
CCD camera and Optimas 6.5 software (CyberMetrics,
Scottsdale, AZ). The Ki67-positive cells in each section
of the dentate gyrus were enumerated using the software
protocol (CyberMetrics). The cell-counts from all of the
sections for each treatment group were averaged into a
single group mean.
Measurement of AChE activity in the hippocampus
To measure AChE activity in synaptosomes, animals
in each group (n = 5) were anesthetized with 1 g/kg
urethane (Sigma-Aldrich) after the novel-object recog-
nition test, and the hippocampi were quickly removed
from the brain and placed into labeled cryo-tubes.
After a quick-freeze in liquid nitrogen for 15 min, the
hippocampi were homogenized in 10 volumes of an
ice-cold medium (medium I), consisting of 320 mM
sucrose, 0.1 mM ethylenediaminetetraacetic acid, and
5 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic
acid, pH 7.5, in a motor driven Teflon-glass homogenizer.
Synaptosomes were isolated using a discontinuous
Percoll gradient, as described by Nagy and Delgado-
Escueta [24]. The pellet was suspended in an isoos-
motic solution, and the final protein concentration
was adjusted to 0.5 mg/mL. Synaptosomes were pre-
pared fresh daily, maintained at 4 °C throughout the
procedure, and used for enzymatic assays. The AChE
enzymatic assay was conducted using a modification
of the spectrophotometric method of Ellman et al.
[25], as described by Rocha et al. [26]. The reaction
mixture (2 mL final volume) contained 100 mM K+-phos-
phate buffer, pH 7.5, and 1 mM 5,5′-dithio-bis-nitro-
benzoic acid. The method is based on the formation
of the yellow anion, 5,5′-dithio-bis-acid nitrobenzoic,
measured by reading absorbance at 412 nm during a
2-min incubation at 25 °C. The enzyme was pre-
incubated for 2 min, and the reaction was initiated by
adding 0.8 mM acetylthiocholine iodide (AcSCh). All
samples were run in duplicate or triplicate and
enzyme activity was expressed in μmol AcSCh/h/mg
of protein.
Statistical analysis
All data are expressed as the mean ± standard error of
the mean (SEM). To determine the effects of
cadmium, DMS, and GAL treatments, differences
between the means were analyzed using one-way ana-
lysis of variance with repeated measures and a Bonferroni’s
post-hoc test. Differences were considered significant
if p ≤ 0.05.
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Results
Effects of cadmium with or without DMS on recognition
memory
During the training period, all rats showed similar
behavioral patterns and spent a similar fraction of time
exploring the identical objects, although the cadmium-
treated group, with or without DMS, showed less activity
exploring the objects compared to the control group.
During the test period, rats in the control and DMS-
treated group spent more time exploring new objects
than familiar ones. In the cadmium-treated group, rats
spent a similar amount of time exploring new and famil-
iar objects and the DI was decreased significantly
compared to that in the control group. In contrast, rats
in the group treated with cadmium and DMS spent
more time exploring new objects than familiar ones and
the DI was increased significantly in this group com-
pared to that of the cadmium-treated group. Rats in the
group treated with cadmium and GAL also spent more
time exploring new objects and the DI was increased in
this group compared to that of the cadmium-treated
group. In the cadmium and GAL group, the DI was
similar to that in the group treated with cadmium and
DMS (F = 17.87, dftotal = 49, dftreatment = 4) (Fig. 1).
Effects of cadmium and/or DMS on cell proliferation in
the dentate gyrus
In the vehicle-treated group, clustered Ki67-positive
nuclei were detected in the subgranular zone of the
dentate gyrus (Fig. 2a). In this group, the number of
Ki67-positive nuclei was 15.6 ± 0.78 per section of the
dentate gyrus. In the DMS-treated group, the number of
Ki67-positive nuclei within the dentate gyrus showed a
significant increase of 52.3 % compared to that in the
vehicle-treated group (Fig. 2b and f). In the cadmium-
treated group, few Ki67-positive nuclei were detectable
in the dentate gyrus, equivalent to only 28.4 % of that
found in the vehicle-treated group (Fig. 2c and f). In the
group treated with cadmium and DMS, the number of
Ki67-positive nuclei was increased significantly in the
dentate gyrus compared to that in the cadmium-treated
group, although the number was lower than that in the
vehicle-treated group (Fig. 2d and f). In the group
treated with cadmium and GAL, the number of Ki67-
positive nuclei was also significantly increased in the
dentate gyrus compared to that in the cadmium-treated
group and the number of Ki67-positive nuclei was
similar to the group treated with cadmium and DMS
(F = 55.07, dftotal = 34, dftreatment = 4) (Fig. 2e and f ).
Effects of cadmium and/or DMS on neuroblast
differentiation in the dentate gyrus
In the vehicle-treated group, DCX-immunoreactive
neuroblasts were detected in the subgranular zone of the
dentate gyrus, and their well-developed dendrites ex-
tended into two-thirds of the molecular layer of the den-
tate gyrus (Fig. 3a and b). In the DMS-treated group, the
distribution pattern of neuroblasts and dendrites in the
dentate gyrus were similar to those in the vehicle-treated
group (Fig. 3c and d). However, in the cadmium-treated
group, DCX-immunoreactive neuroblasts showed a
decrease in number and a shortening of the dendrites in
the dentate gyrus compared to those in the vehicle-
treated group (Fig. 3e and f). In the group treated with
cadmium and DMS, the DCX-immunoreactive neurons
had well-developed dendrites and the number of DCX-
immunoreactive neurons significantly increased compared
to that in the cadmium-treated group (Fig. 3g and h). In
the group treated with cadmium and GAL, DCX-
immunoreactive neurons were abundantly observed in the
Fig. 1 Effect of treatment on exploration time and discrimination index
of familiar vs. new objects in the novel-object recognition test in rats.
*indicates a significant difference between the vehicle-treated and
cadmium (Cd)-treated groups; # indicates a significant difference
between the vehicle and Dendropanax morbifera Léveille stem extract
(DMS) (or galantamine [GAL]) treatment groups; † indicates a significant
difference between the familiar and new object (p< 0.05; n= 10 per
group). The data are shown as mean ± SEM
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dentate gyrus, and they also had well-developed den-
drites compared to those in the cadmium-treated
group (Fig. 3i and j).
Effects of cadmium and/or DMS on AChE activity in the
hippocampal homogenates
In the vehicle-treated group, AChE activity was
4.47 μmol AcSCh/h/mg protein in the hippocampal ho-
mogenates. In the DMS-treated group, this activity was
higher than that in the vehicle-treated group; however, a
significant difference was not found. In the cadmium-
treated group, AChE activity was decreased significantly
to 56.4 % of that in vehicle-treated group. In the
cadmium and DMS-treated group, as well as in the
groups treated with cadmium and GAL, AChE activity
showed a significant increase of 55.6 % and 72.2 %, re-
spectively, compared to that of the cadmium-treated
group (F = 11.36, dftotal = 24, dftreatment = 4) (Fig. 4).
Discussion
Cadmium readily accumulates in tissues (with an ap-
proximately 30-year half-life in humans), including the
vascular endothelium of the brain, where it effects the
integrity and permeability of the blood-brain barrier
[17, 27–29]. In the present study, we observed the ef-
fects of cadmium on hippocampal function based on
novel-object recognition memory. We observed that
the administration of cadmium caused decreased
exploratory activity, as well as a decrease in novel
object recognition. This result is consistent with that
of previous studies that showed that acute administra-
tion of cadmium had depressogenic effects and decreased
locomotor activity [30, 31]. In addition, cadmium de-
creases cognitive functions in humans [32] and induces
neuronal death in basal forebrain cholinergic neurons
[33]. Furthermore, cadmium treatment facilitates an
increase in the number and size of senile plaques and pro-
motes memory impairments [34]. In the present study,
Fig. 2 Immunohistochemistry for Ki67 in the dentate gyrus of treated rats. Ki67 immunostaining in rats treated with vehicle (a), Dendropanax
morbifera Léveille stem extract (DMS; b), cadmium alone (Cd; c), cadmium and DMS (Cd-DMS; d), and cadmium plus galantamine (Cd-GAL) (e). In
the vehicle-treated group, Ki67-positive nuclei (arrows) are detectable in the subgranular zone of the dentate gyrus. Note that there are few Ki67-positive
nuclei in the Cd-treated group; however, they are comparatively abundant in the Cd-DMS-treated and Cd-GAL-treated groups. GCL, granule cell layer; ML,
molecular layer; PoL, polymorphic layer. Scale bar = 100 μm. f: Quantitative analysis of Ki67-positive nuclei per section in the vehicle,
DMS-treated, Cd-treated, DMS-Cd-treated, and DMS-GAL-treated rats using an image analyzer (n = 5 per group); * indicates a significant
difference between the vehicle and Cd groups (p < 0.05); # indicates a significant difference between the vehicle and DMS (or GAL)
groups (p < 0.05; n = 5 per group). The data are shown as mean ± SEM
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the administration of cadmium with DMS ameliorated the
decreased locomotor activity and improved the DI in a
novel-object recognition test. D. morbifera extract is
shown to have neuroprotective effects against heavy
metal-induced oxidative damage [15, 35] and rotenone-
induced dopaminergic cell death [36]. Extracts from the
leaves and stems of D. morbifera decreases both
cadmium-induced and mercury-induced oxidative damage
in the hippocampus [15, 35]. Furthermore, rutin, isolated
from D. morbifera Léveille, significantly decreased
rotenone-induced dopaminergic cell death by ameliorating
rotenone-induced c-Jun N-terminal kinase and p38
mitogen-activated protein kinase phosphorylation in
SH-SY5Y cells [36].
Rapid depletion of actively dividing neurogenic cells
and approximately 90 % of DCX-expressing cells by
X-ray irradiation significantly decreases novel-object rec-
ognition [37]. In addition, the temporal requirement
(i.e., 3 days) of neurogenesis after reactivation for recon-
solidation is the same as that found for consolidation
[38]. During novel-object recognition, the hippocampus
is involved in the identification of spatial changes in ob-
ject position and detection of novelty [39]. In the present
study, we studied the effects of cadmium on the hippo-
campus because it is one of the brain regions most
vulnerable to toxic materials. The administration of
cadmium significantly reduced cell proliferation, neuro-
blast differentiation, and AChE activity in the hippocam-
pus. Previous reports indicated that exposure to cadmium
decreases AChE activity, increases oxidative damage in
the hippocampus [18], and reduces neuronal differenti-
ation and axonogenesis during embryonic brain develop-
ment of zebrafish [40]. However, this is the first report of
cadmium affecting neurogenesis in the adult brain.
Extracts from the leaves of D. morbifera suppress the
production of pro-inflammatory cytokines and increase
anti-inflammatory marker genes in lipopolysaccharide-
stimulated BV2 cells [41]. In the present study, we also
Fig. 3 Immunohistochemistry for DCX in the dentate gyrus of
treated rats. Images of doublecortin (DCX) immunostaining in rats
treated with vehicle (a, b), Dendropanax morbifera Léveille stem
extract (DMS; c, d), cadmium alone (Cd; e, f), cadmium and DMS
(Cd-DMS; g, h), and cadmium and galantamine (Cd-GAL; i, j). In the
vehicle-treated group, DCX-immunoreactive neuroblasts are observed
in the subgranular zone with well-developed dendrites (arrows) extending
into the molecular layer (ML). Note that there are few DCX-immunoreactive
neuroblasts in the Cd-treated group, and they have poorly developed
dendrites. In the Cd-DMS-treated and Cd-GAL-treated groups, there are
abundant DCX-immunoreactive neuroblasts and their dendrites are well
developed. GCL, granule cell layer; PoL, polymorphic layer. Scale
bar = 100 μm (a, c, e, g, and i) and 33 μm (b, d, f, h, and j)
Fig. 4 Acetylcholinesterase (AChE) activity in hippocampal
synaptosomes. Graph showing hippocampal AChE activity in rats
treated with vehicle, Dendropanax morbifera Léveille stem extract
(DMS), cadmium alone (Cd), cadmium and DMS (Cd-DMS), or cadmium
and galantamine (Cd-GAL). * indicates a significant difference between
the vehicle and Cd groups (p< 0.05); #indicates a significant difference
between the vehicle and DMS (or GAL) groups (p< 0.05; n= 5 per
group). The data are shown as mean ± SEM
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investigated the effects of DMS on the cadmium-induced
decrease in hippocampal function. Administration of
DMS significantly ameliorated cadmium-induced impair-
ment of novel-object recognition memory. In addition,
DMS increased cell proliferation, neuroblast differenti-
ation, and AChE activity in the hippocampus, thus
countering the effects of cadmium exposure. DMS had a
comparable potency to GAL in terms of increasing cell
proliferation, neuroblast differentiation, and AChE activity
in the hippocampus. GAL has been reported to in-
crease neurogenesis in the subgranular zone of the
dentate gyrus and in the subventricular zone of the
lateral ventricle [19–21]. Collectively, our results sug-
gest that the administration of DMS significantly
increases cell proliferation and neuroblast differenti-
ation by promoting AChE activity in the dentate
gyrus, where AChE is highly expressed in proliferating
and differentiating cells and is likely involved in neur-
ite outgrowth [42–44]. This conclusion is supported
by previous studies that showed that AChE is in-
volved in progenitor-cell proliferation and differenti-
ation [45], and modulation of the cholinergic system
significantly alters hippocampal neurogenesis [46, 47].
The mechanism of DMS action was not demonstrated
in this study; however, DMS has possible neuropro-
tective effects against cadmium-induced neurotoxicity.
Rutin and/or its metabolites, components arising from
DMS, are able to cross the blood brain barrier [48, 49],
and rutin may reduce memory deficits in Alzheimer’s
disease [50].
Conclusion
Repeated exposure to cadmium causes memory impair-
ment and reduces cell proliferation, neuroblast differen-
tiation, and AChE activity. The administration of DMS
effectively ameliorates these cadmium-induced effects by
maintaining AChE activity in the hippocampus.
Abbreviation
AChE: Acetylcholinesterase; AcSCh: Acetylthiocholine iodide; DCX: Doublecortin;
DI: Discrimination index; DMS: D. morbifera stem extract; GAL: Galantamine;
PBS: Phosphate-buffered saline; SEM: Standard error of the mean
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